Farquhar, H. (2026). Real-World Safety Profile of Xanomeline-Trospium (Cobenfy), the First Muscarinic Agonist Antipsychotic: A Disproportionality Analysis of the FDA Adverse Event Reporting System. Zenodo.
Chicago Style (17th ed.) CitationFarquhar, Hayden. Real-World Safety Profile of Xanomeline-Trospium (Cobenfy), the First Muscarinic Agonist Antipsychotic: A Disproportionality Analysis of the FDA Adverse Event Reporting System. Zenodo, 2026.
MLA (9th ed.) CitationFarquhar, Hayden. Real-World Safety Profile of Xanomeline-Trospium (Cobenfy), the First Muscarinic Agonist Antipsychotic: A Disproportionality Analysis of the FDA Adverse Event Reporting System. Zenodo, 2026.
Warning: These citations may not always be 100% accurate.